Evidence map›Paper›PMID 33533536›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2021

Applications of artificial intelligence for hypertension management.

Kelvin Tsoi, Karen Yiu, Helen Lee, Hao-Min Cheng, Tzung-Dau Wang, Jam-Chin Tay, Boon Wee Teo, Yuda Turana, Arieska Ann Soenarta, Guru Prasad Sogunuru and 7 more

Abstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Updates in the management of hypertension.Annals of medicine and surgery (2012) · 2024
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kelvin TsoiSH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong.ORCID 0000-0001-5580-7686
Karen YiuSH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong.
Helen LeeJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
Hao-Min ChengDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Tzung-Dau WangCardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
Jam-Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
Boon Wee TeoDivision of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore.
Yuda TuranaDepartment of Neurology, School of Medicine and health Sciences, Atma Jaya Catholic University of Indonesia, Indonesia.
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Guru Prasad SogunuruDepartment of Cardiology, MIOT international hospital, Chennai, India.
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.
Yook-Chin ChiaDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.
Chen-Huan ChenDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
HOPE Asia Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of hypertension is increasing along with an aging population, causing millions of premature deaths annually worldwide. Low awareness of blood pressure (BP) elevation and suboptimal hypertension diagnosis serve as the major hurdles in effective hypertension management. The advent of artificial intelligence (AI), however, sheds the light of new strategies for hypertension management, such as remote supports from telemedicine and big data-derived prediction. There is considerable evidence demonstrating the feasibility of AI applications in hypertension management. A foreseeable trend was observed in integrating BP measurements with various wearable sensors and smartphones, so as to permit continuous and convenient monitoring. In the meantime, further investigations are advised to validate the novel prediction and prognostic tools. These revolutionary developments have made a stride toward the future model for digital management of chronic diseases.

Indexed as

HypertensionTelemedicineAgedArtificial IntelligenceHumans

Identifiers

PMID33533536
PMCPMC8029548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.